Share Radio Afternoon
AstraZeneca revenues fall, but CEO promises "pivotal year"
Pharmaceutical giant AstraZeneca saw its revenues fall 12% in its Q1 results, but CEO Pascal Soriot has promised that new drugs on the horizon for 2017 will start to come through and give the company a boost. Is it enough to satisfy shareholders? Ed Bo...